Clinical Trial Update: Dexmedetomidine Versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dexmedetomidine versus ketofol for moderate sedation in endoscopic retrograde cholangiopancreatography has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ketofol (ketamine/propofol combination)

Snippet

Sponsor: Sindh Institute of Urology and Transplantation | Conditions: Sedation | Phase 4 | Status: COMPLETED